Epigenetics Market Share Analysis | 2023-2028

"Global Epigenetics Market is estimated to grow from USD 8.13 billion in 2022 to USD 23.52 billion by 2028 at a CAGR of 19.16% during the forecast period".

To study in detail about this report, Click here.

Market Dynamics

Introduction

Epigenetics refers to a stream of genetics that involves the study of physiological and cellular trait variations initiated by external or ecological aspects, which turns genes on and off and affects the cellular ability to read the genes without being impacted by changes in genotype. It results in changes in the phenotype of an organism rather than the genotype, where the underlying RNA or DNA sequence remains unchanged. Epigenetic alterations are vital for development as they are dynamic and change as per the surrounding environment stimuli.

Market Drivers

The growing prevalence of cancer and other chronic diseases coupled with the increasing aging population is expected to bolster the product demand of epigenetics market:

• The increasing need to understand epigenetic modifications at the molecular level and the advancement of therapeutic solutions are likely to encourage government organizations to fund R&D programs, further bolstering market growth.
• Furthermore, various initiatives such as the Epidemiology and Genomics Research Program (EGRP) provide incentives to research activities for product innovation that are working towards an understanding of cancer causes and their related outcomes.

Want to take a closer look at this report? Register here.

COVID-19 Impact

The COVID-19 pandemic has moderately affected the epigenetics industry. Few therapeutic combinations have been studied to cure this viral infection. Researchers have analyzed how epigenetics may prevent viral proliferation so that vaccines and therapeutics for COVID-19 can be synthesized to specifically target the replicating mechanisms of a virus. This, in turn, positively stimulates market growth.

Segment Analysis

Epigenetics Market: Product Trends

 "The reagents segment garnered the highest market share in 2020".

Based on product, the global epigenetics market has been segmented into reagents, kits, instruments, enzymes, and services. Among these, the reagents segment garnered the highest market share in 2020 and is likely to register a healthy CAGR during the assessment period. Histone and DNA modifiers are the most common types of reagents used for epigenetics and are predominantly used for treating various medical conditions.

Epigenetics Market: Regional Trends

"The North American market accounted for the largest market share of over 40% in 2020". 

By region, the North American market accounted for the largest market share of over 40% in 2020 and is likely to grow at a steady CAGR during the review period. This can be attributed to significant funding for research activities on epigenetics in the US and the presence of many key healthcare companies, thus accelerating regional market growth. Also, ongoing developments in diagnostic procedures and the presence of modern healthcare facilities are positively influencing the growth of the regional market.

To get more information about this report, Click here.

Target Audience

The following are the key players in the Epigenetics Market  (arranged alphabetically)

• Abcam plc (UK),
• Active Motif (The US),
• CellCentric (UK).
• Diagenode Diagnostics (Belgium),
• F. Hoffmann-La Roche Ltd. (Switzerland),
• Eisai Co., Ltd. (Japan),
• Illumina, Inc. (The US),
• Merck Sharp & Dohme Corp (The US),
• Novartis AG (Switzerland),
• Qiagen (Germany),
• Zymo Research Corporation (The US), and

Note: The above list does not necessarily include all the top players in the market.

Are you the leading player in this market? We would love to include your name. Please write to us at [email protected]

Report Features

This report provides market intelligence most totally. The epigenetics market report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market. 

What Deliverables Will You Get in this Report?

Research Methodology

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

Customization Options

Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to three players)
• SWOT analysis of key players (up to three players)

Competitive Benchmarking

Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected].